vimarsana.com
Home
Live Updates
Teva, mAbxience ink global licensing agreement for oncology biosimilar candidate : vimarsana.com
Teva, mAbxience ink global licensing agreement for oncology biosimilar candidate
The licensing agreement covers multiple global markets, including Europe and the United States.
Related Keywords
Argentina ,
United States ,
Spain ,
Insud Pharma ,
Jurgen Van Broeck ,
Fresenius Kabi ,
Teva Pharmaceutical Industries ,
Teva Pharmaceuticals International Gmb ,
Teva Pharmaceuticals International Gmbh ,
Good Manufacturing Practice Approved ,
Angus Grant ,
vimarsana.com © 2020. All Rights Reserved.